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Objective: To evaluate whether a new biphasic cement composed of calcium sulfate and beta
tricalcium phosphate with zeta potential control could induce or lead to bone neoformation
in  critical defects.
Methods: A critical defect of diameter 8 mm was made in the calvaria of forty male Wistar
rats. In the Test Group (n = 20), the defects were ﬁlled with cement. In the Control Group
(n  = 20), the defect was not ﬁlled and only coagulum was present. The animals were sac-
riﬁced 7, 14, 21 and 42 days after the operation. Calvaria specimens were subjected to
microtomography and were then prepared for histological analysis. The analyses included
morphological assessment on the histopathology of the repair; comparative morphometric
evaluation of the area of formation of bone trabeculae between the groups; and histo-
chemical staining by means of tartrate-resistant phosphatase (TRAP) in order to identify
osteoclasts.
Results: Microtomographic images of the defects ﬁlled by the cement did not show any
decrease in area over the course of postoperative evolution. In the Test Group, the material
continued to present a foreign-body response until the last observational periods. Histomor-
phological analysis showed that there were more signiﬁcant groupings of giant cells in theTest Group and greater maturity of neoformed bone in the Control Group. Exogenous mate-
rial  was also present. Histomorphometric analysis showed that in the Control Group, thetotal  area of bone neoformation was signiﬁcantly greater (p = 0.009) and grew progressively.
The  giant cells presented a positive reaction to TRAP but no osteoclasts were observed.
 Study carried out at the Department of Surgery, Prosthesis and Oral and Maxillofacial Traumatology, Faculdade de Odontologia,
Universidade de São Paulo (USP), São Paulo, SP, Brazil.
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Conclusion: The ceramic cement did not induce or lead to bone neoformation from the
microtomographic or histological point of view.
©  2015 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora
Ltda. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Efeito  adverso  do  beta-fosfato  tricálcico  com  controle  de  potencial  zeta  no
reparo  de  defeitos  críticos  em  calvária  de  ratos
Palavras-chave:
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Objetivo: Avaliar se um novo cimento bifásico composto por sulfato de cálcio e beta fosfato
tricálcico com controle de potencial zeta poderia induzir ou conduzir a neoformac¸ão óssea
em defeitos críticos.
Métodos: Foi feito um defeito crítico de 8 mm de diâmetro na calvária de 40 ratos Wistar
machos. No grupo teste (n = 20) os defeitos foram preenchidos pelo cimento. No grupo
controle (n = 20) os defeitos não foram preenchidos, permaneceu apenas o coágulo. Os ani-
mais  sofreram eutanásia em 7, 14, 21 e 42 dias do pós-operatório. Espécimes da calvária
foram microtomografados e posteriormente preparados para análise histológica. As análises
incluíram a avaliac¸ão morfológica da histopatologia do reparo e a avaliac¸ão morfométrica
da  área de formac¸ão das trabéculas ósseas comparativamente entre os grupos e colorac¸ão
histoquímica por meio da fosfatase tartrato-resistente (TRAP) para identiﬁcac¸ão de osteo-
clastos.
Resultados: As imagens microtomográﬁcas dos defeitos preenchidos pelo cimento não apre-
sentaram diminuic¸ão da área de acordo com a progressão dos períodos pós-operatórios. No
grupo  teste houve permanência do material e resposta corpo estranho até os últimos perío-
dos  de observac¸ão. A histomorfologia mostrou agrupamentos mais expressivos de células
gigantes no grupo teste e osso neoformado mais maduro no grupo controle e comprovou a
presenc¸a  de material exógeno. Na histomorfometria, a área total de neoformac¸ão óssea foi
signiﬁcativamente maior (p = 0,009) e crescente no grupo controle. As células gigantes apre-
sentaram expressão histoquímica positiva para TRAP e não foram observados osteoclatos.
Conclusão: O cimento cerâmico não induziu ou conduziu a neoformac¸ão óssea sob o ponto
de  vista microtomográﬁco e histológico.
© 2015 Sociedade Brasileira de Ortopedia e Traumatologia. Publicado por Elsevier
Editora Ltda. Este e´ um artigo Open Access sob uma licenc¸a CC BY-NC-ND (http://
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the microtomographic and histological point of view, whetherntroduction
utogenous graft is still the material of choice for the
econstruction of bone tissue loss in orthopedic and maxillo-
acial surgery. However, increase in operation time, surgical
rauma and possible complications inherent to the donor area
pproach does not always make it feasible. New biomateri-
ls and substances that can mimic  the characteristics of the
utogenous bone tissue have been a constant pursuit of bio-
ngineering.
Among the alloplastic materials most often used nowadays
re bioceramics, mainly hydroxyapatite and beta-tricalcium
hosphate (-TCP). The latter shows a more  rapid biodegrada-
ion than hydroxyapatite and in some situations this may be
 more  advantageous characteristic for a biomaterial, mainly
hen there is no need for mechanical strength. Moreover,
eta-tricalcium phosphate has been widely used as a carrier
r scaffold in tissue engineering.Recently, a biphasic ceramic material consisting of calcium
ulfate and beta-tricalcium phosphate with a negative sur-
ace charge, called zeta potential control, was launched in thecreativecommons.org/licenses/by-nc-nd/4.0/).
international market with the proposal of making beta-
tricalcium phosphate an inductive bone substitute and thus,
promote bone regeneration.1
According to the manufacturer,2 this ceramic is fully
synthetic and has what they called “intelligent porosity”,
which facilitates cell growth and nutrient distribution in the
extracellular matrix internally in the macroporosities of this
compound. Some authors have demonstrated intense bone
regeneration capacity in vertebral defects in sheep.1
The osteogenic potential of this compound, however, has
been questioned. Some authors have shown concern about the
biological safety of the product.3 Other researchers4 discontin-
ued early clinical trials due to the appearance of unexpected
adverse effects, such as aseptic inﬂammation and delayed
repair. The literature is scarce on the analysis of the biolog-
ical behavior of this new biomaterial in bone repair in in vivo
studies.
In this context, we propose an in vivo study to assess, fromthis bioceramic compound can induce or lead to bone neofor-
mation in critical defect models in rat calvaria.
p . 2 0 
with bone wound repair was used as a positive control for348  r e v b r a s o r t o 
Material  and  methods
Experimental  procedure
This research project was approved by the Institutional Ethics
Committee on Animal Use (CEUA) under protocol number
006/2014 and in accordance with the ethical principles of
animal experimentation adopted by the Brazilian Society for
Laboratory Animal Science (SBCAL).
Forty (40) male Wistar rats (Rattus norvegicus albinus),
weighing between 200 g and 250 g and aged approximately
45 days, were operated on under general anesthesia by
intramuscular injection in the right rear paw of each ani-
mal  of ketamine hydrochloride (Dopalen®, Vetbrands) at a
dose of 0.8 mg/kg associated with muscle relaxant xylazine
(Rompum®, Bayer) at a dose of 0.3 mg/kg. All animals
received antibiotic prophylaxis through intramuscular injec-
tion of benzathine benzylpenicillin (Roche®) at a dose of
150,000 IU/kg.
After trichotomy, followed by skin antisepsis with 2%
chlorhexidine digluconate, an access was made to the cal-
varia through a 2 cm-rectilinear incision in the skin of the
medial region of the skull, extending from the nasofrontal
area to the occipital protuberance. The skin, subcutaneous
tissue, temporal muscle and the periosteum were divulsed
laterally.
A bone defect was created in the central region of the
animal calvaria using an 8 mm-diameter steel trephine drill
(Sistemas de Implantes Nacionais – SIN®), adapted to a
counter-angle implant motor (Driller® – Carapicuíba – São
Paulo) under low speed and constant irrigation with 0.9%
saline solution.
The animals were randomly divided into two groups: Test
Group (n = 20), which received cement consisting of beta tri-
calcium phosphate (-TCP) and calcium sulphate at a ratio of
1:1 (Genex – Biocomposites® – Staffordshire – England) to ﬁll
the critical defect in the calvaria at the amount of 25 mm3 per
defect, and the Control Group (n = 20), which remained with
the critical defect ﬁlled only by a clot.
Synthesis of the skin was performed with 3/0 silk thread
(Ethicon®). Throughout the study period, the animals were
kept in ventilated polypropylene cages, covered with steril-
ized wood shavings, with day/night cycles of 12/12 h, and were
fed rodent chow (Labina for Rodents, Purina®) and water ad
libitum.
Five animals from each group were euthanized in a CO2
chamber after 7, 14, 21 and 42 days postoperatively. After
euthanasia, the skulls were dissected and representative frag-
ments of the calvaria with the defect area were ﬁxed in 10%
buffered formalin.
Prior to the processing and histological analysis, a speci-
men  from a rat in the Test Group and from a rat in the Control
Group, in each of the study periods, were submitted to micro-
tomography in a 100 kV to 100 A SkyScan microtomographer
in the Department of Animal Physiology of the Biology Insti-
tute of Universidade de São Paulo.The samples were placed at and ﬁxed to the equipment cell,
which was set for a resolution of 2000 × 2000 pixels and 16 m
sections. The time of image  acquisition was approximately 2 h1 6;5 1(3):346–352
per sample. Images were analyzed and reconstructed in two
and three dimensions, using the InVesalius sofware (Division
of Three-Dimensional Technologies of Centro de Tecnologia
da Informac¸ão de Campinas – São Paulo).
The biomaterial volume was quantiﬁed in cubic millime-
ters (mm3). In the two-dimensional images, the sagittal and
axial distances of the bone defect and three-dimensional axial
distance were measured in millimeters (mm).
For the histological analysis, the specimens (n = 5) from
each group and preoperative observation period were
immersed in 10% EDTA solution (pH 7.4) for six weeks for
bone tissue decalciﬁcation. The defect area was sectioned
in half, exactly at the median sagittal plane of the rat cal-
varia, which resulted in two parts of the wound: the left
side and the right side (S1 and S2). Each side of the defect
was embedded in parafﬁn and subsequently, four 4.5 cm-thick
parasagittal sections were obtained and stained with Masson
trichrome. Histological sections were assessed using a conven-
tional light microscope (Olimpus® CH2, Olympus Optical Co.
Ltd., Japan) in a blinded fashion by an experienced patholo-
gist. The histomorphological aspects considered the presence
of the following repair characteristics: edema, inﬂammatory
inﬁltrate, granulation tissue, bleeding/blood clot, bone neofor-
mation, foreign body reaction and the presence of exogenous
material. The parameters were weighed using an arbitrary
scale by the following scores: 0 = absent; 1 = mild; 2 = mild to
moderate; 3 = moderate to intense and 4 = intense.
The histomorphometric analysis was used to quantify the
neoformed bone tissue area in randomly selected sections on
both halves (left and right) in three regions of the wound, the
anterior region (close to the nasal bone), the central region and
the posterior region (close to the occipital bone). Histological
images of each region were obtained with a 40× magniﬁcation
using a CCD camera (Sony®) coupled to a microscope (Jeol®)
and an image  capture board (Captivator®).
Then, these images were transferred to a digital morphom-
etry software program (ImageJ, NIH – National Institutes of
Health). The formation of neoformed trabecular bone was
identiﬁed and delimited using a hand free software tool. Mea-
surements were performed in four semi-serial histological
sections of each slide.
The total area of bone neoformation was obtained at each
ﬁeld and added to the value obtained on the opposite side of
the wound. At the end, mean was calculated for the total area
of neoformed bone tissue for each group and period.
In order to identify osteoclastic cells, two randomized cuts
on each side of the wound from two animals from each group
were randomly chosen and submitted to histochemical stain-
ing to demonstrate tartar phosphatase-resistant acid (TRAP).
Histological sections were incubated for 3 h at room tempera-
ture, in solution containing sodium tartrate, tartaric acid and
disodium salt (SigmaTM).
After incubation, the sections were rinsed in tap water,
allowed to air dry at 25 ◦C and counterstained with 1%
fast green (Fisher Scientiﬁc Co.) for approximately 1 min. A
mouse femur section (stored parafﬁn-embedded material)this immunohistochemical reaction. After staining, the slides
were kept in dark ﬁeld to be subsequently assessed under light
microscopy.
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Table 1 – Volume of remaining material and microtomographic two-dimensional, three-dimensional measurements of
bone defects according to the periods of postoperative observation in the Test and Control Groups.
Period Group n Volume of biomaterial (mm3) Two-dimensional distances Tridimensional axial distance (mm)
Axial Sagittal
7 days Control 1 8.97 8.95 8.96
Test 1 25.11 8.32 8.16 9.39
14 days Control 1 9.46 9.41 9.50
Test 1 10.96 7.72 10.81 7.34
21 days Control 1 8.41 8.58 8.15
Test 1 7.00 7.77 9.55 9.51
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Histological data were analyzed by nonparametric inferen-
ial statistics using the Mann–Whitney test with the Biostat
.0 software with a signiﬁcance level of 5%.
esults
he results of microtomographic image  analysis are shown in
able 1 and Fig. 1. The intensity in gray levels of the bioma-
erial was close to that of bone, but the biomaterial showed
ranularity, allowing it to be differentiated from bone.
Histological examination regarding repair morphology is
hown in Table 2 and main histological aspects are shown
n Fig. 2. Fig. 3 shows the result of staining for TRAP (tar-
rate -resistant acid phosphatase) in the Test Group 42 days
ostoperatively.
Results of the histomorphometric analysis of bone neofor-
ation area are shown in Fig. 4.
ig. 1 – Coronal view of the calvaria defects reconstructed by Mic
bservation periods. At (a) 7 days, (b) 14 days, (c) 21 days and (d) 
mage without bone neoformation. At (e) 7 days, (f) 14 days, (g) 1
n blue the remaining volume of TCP cement. 8.56 9.06
 11.51 11.10
Discussion
The literature describes that calcium phosphates and their
derivatives, including beta-tricalcium phosphate, act more
directly on osteoblasts and have been extensively studied as
bone replacement for more  than two decades, as they pro-
mote bone neoformation by osteoconduction and have good
biocompatibility.5–7
Its effects as inorganic scaffold for bone tissue regeneration
are already well documented, including dental lesions,8–11 in
spite of still controversial ﬁndings, ranging from bone neo-
formation that is superior to the one observed in autogenous
grafts12 and anorganic bovine bone graft,13 to robust evidence
of insufﬁcient osteogenesis.14,15The biomaterial used in this study (GeneX®) is relatively
new and it is a ceramic compound, which has negative sur-
face charge control. Investigations about its efﬁcacy have
roCT in the control and Test Groups according to the
42 days after surgery the Control Group show the defect
4 days and (h) 42 days after surgery, the Test Group shows
350  r e v b r a s o r t o p . 2 0 1 6;5 1(3):346–352
Table 2 – Values of the medians [max–min] of the score intensities for the histological variables of the bone defect.
Variables 7  days 14 days 21 days 42 days
Control Test p Control Test p Control Test p Control Test p
Edema 2 [2-1] 1 [2-1] 0.22 2 [2-1] 1 [1-0] 0.075 1 [1-0] 1 [1-0] 1 0 [2-0] 0 [1-0] 0.916
Inﬂammatory inﬁltrate 1 [2-1] 4 [4-4] 0.004 1 [3-1] 4 [4-3] 0.008 1 [1-0] 4 [4-4] 0.003 1 [1-0] 4 [4-3] 0.006
Granulation tissue 3 [4-3] 3 [3-2] 0.212 2 [3-1] 4 [4-3] 0.011 1 [1-1] 2 [3-2] 0.004 1 [2-1] 1 [1-1] 0.317
Hemorrhage/thrombus 3 [3-1] 2 [3-1] 0.496 2 [3-2] 1 [4-0] 0.193 3 [3-1] 0 [4-0] 0.106 2 [3-0] 1 [3-0] 0.335
Bone neoformation 1 [2-1] 1 [1-1] 0.317 2 [2-1] 2 [3-1] 0.605 2 [3-1] 2 [2-1] 0.339 2 [3-1] 1 [2-1] 0.418
Foreign body reaction 0 [1-0] 4 [4-4] 0.005 1 [2-1] 4 [4-4] 0.005 0 [2-0] 4 [4-3] 0.007 1 [2-0] 4 [4-3] 0.006
Exogenous material 0 [0-0] 4 [4-3] 0.007 0 [0-0] 4 [4-4] 0.005 0 [0-0] 2 [3-2] 0.005 0 [0-0] 3 [4-2] 0.008
0, absent; 1, mild; 2, mild to moderate; 3, moderate to intense; 4, intense.
P values for Kruskall–Wallis test. Signiﬁcant when p < 0.05.
Mann–Whitney test is signiﬁcant when p < 0.05.
most often focused on repair defects of the spine or long
bones.16 Yang et al.1 demonstrated in an in vivo study that this
ceramic material promoted superior bone formation in verte-
bral defects in eight weeks when compared with the use of a
polymer cement (polymethylmethacrylate). However, in their
conclusions, they indicate that the -TCP ceramic needs to be
further assessed.
As the manufacturer’s proposal was to add a surface treat-
ment on the ceramic particles that allowed osteoinduction, a
critical bone defect model would provide important informa-
tion if the bone neoformation occurred where it would not be
expected.
This type of model is quite often described in the litera-
ture and it is, in a way, acknowledged for this type of in vivo
Fig. 2 – Histological sections representative of critical defects in e
In (A) Control Group – 21 days, shows deposition of collagen and
Test Group – 21 days, shows exogenous material cluster (long ar
connective tissue (short arrow). In (C) Control Group – 42 days, sh
defect borders (arrow). In (D) intense deposition of ﬁbrous conne
adjacent giant cells (arrow) (Masson staining, magniﬁcation 2.5×assay.17–24 We used the critical defect model in rat calvaria
because it is easy to create, reproduce and the fact that an
8 mm-extension defect would allow us to verify the occur-
rence of osteoconduction or induction of the material in a
standardized and reliable manner.
Contrary to the favorable outcome described by German
researchers,25 our results did not show bone neoformation
after insertion of this ceramic compound in ﬁlling defects.
Cement with zeta potential control did not stimulate bone
neoformation in critical defects created in rat calvaria or
showed rapid absorption by the volume of exogenous material
observed in microtomographic images in all study periods.
Recently, Saadoun et al.3 and Friesenbichler et al.4 showed
signiﬁcant complications of this material on tissues when
ach group in the periods of 21 and 42 days postoperatively.
 osteoid matrix adjacent to the defect border (arrow). In (B)
row) encapsulated by intense deposition of ﬁbrous
ows bone deposition of mature and immature bone on the
ctive tissue and clusters of exogenous material and nests of
).
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Fig. 3 – Positive expression of tartrate-resistant acid
phosphatase (TRAP) of multinucleated giant cells (large
arrows) adjacent to the exogenous material clusters (thin
arrows) – Test Group period of 42 days (TRAP staining,
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Magniﬁcation 40×).
sed to ﬁll bone defects in clinical trials, although Laycock
nd Cooper26 attributed these adverse effects to the still inad-
quate use of this biomaterial.
Obviously, the presence of a signiﬁcantly higher amount of
nﬂammatory inﬁltrate in the Test Group is directly related to
he greater response to the presence of a foreign body when
ompared to the Control Group. The fact that the foreign body
esponse remained for the entire duration of the experiment
an lead to the formation of material clusters, which should
e expelled from the wound area in the encapsulated form.
his fact may help to explain the description of “soft tissue
ysts” made by Friesenbichler et al.4
The clinical relevance of this study should be emphasized
rom the histopathological point of view, because there were
7 days 14 days 21 days
Periods of observation
Kruskall-Wallis test – Significant when P<.05
Area of bone neoformation
42 days
1 600 000
P=.009
P=.009
Test groupControl group
P=.009
P=.0283
µm
 2
1 400 000
1 200 000
1 000 000
800 000
600 000
400 000
200 000
0
ig. 4 – Histomorphometric analysis for the area (m2) of
one neoformation related to the groups and periods.
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no standardized experimental preclinical studies to disclose
the behavior of this material on the repair of healthy bone
tissue yet.
According to the histomorphometric ﬁndings, the proposal
of a more  signiﬁcant bone neoformation in the Test Group was
not demonstrated either. The results show that bone forma-
tion was more  intense and signiﬁcantly higher in the Control
Group and denied our hypothesis of trying to demonstrate the
osteoinductive potential promised by the manufacturer.
Results showed that the superiority in bone formation in
controls led us to believe that this ceramic composite pre-
vented the small bone formation that would occur in the
defect.
Our results are also in accordance with those from other
authors,27,28 according to whom the application of other types
of beta-tricalcium phosphate for bone loss repair, in minor
defects and crossover studies in the same animal did not inﬂu-
ence the amount of bone formation.
To assess whether there was increased osteoclastogenesis
and increased bone resorption, a histochemical reaction was
carried out by TRAP staining in the wound area. However, the
foreign body response giant cells were the ones that showed
positivity for this biochemical marker. This may lead to the
hypothesis that the material in the tissue might possibly have
induced speciﬁc biochemical signals.
Thus, giant cells, probably in an attempt to absorb
exogenous material, might also have resorbed bone. Stud-
ies demonstrating the expression of other speciﬁc markers
related to repair and induction of bone tissue formation could
be carried out to better explain this fact.
By the time this study was planned, we  expected to ﬁnd
beneﬁcial effects of Genex® in bone regeneration, especially
considering that this material had favorable reports in clinical
use. Finally, our results are relevant, as they conﬁrm that this
type of ceramic must be reconsidered as a bone substitute.
Conclusion
Within the limitations of this study, the biphasic ceramic
cement consisting of calcium sulfate and beta-tricalcium
phosphate and zeta potential did not induce or resulted in
bone neoformation of 8 mm critical bone defects created in rat
calvaria from the microtomographic and histological points of
view.
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